Jaypirca (pirtobrutinib) is a prescription medication approved for the treatment of certain types of non-Hodgkin lymphoma [1]. Availability at local pharmacies depends on several factors, including whether the pharmacy is equipped to handle specialty medications and the patient's insurance coverage [2].
Can I get Jaypirca at any pharmacy?
Jaypirca is considered a specialty medication, which means it is often not stocked at all retail pharmacies [2]. Patients may need to obtain it from a specialty pharmacy. Your healthcare provider and insurance company can help determine which pharmacies are in your network and can dispense Jaypirca [2].
How does a specialty pharmacy differ from a regular pharmacy?
Specialty pharmacies are equipped to handle complex medications like Jaypirca. This includes managing specific storage and handling requirements, providing patient education on how to take the medication and manage side effects, and often assisting with insurance authorization and financial assistance programs [2].
What is the approval status and indication for Jaypirca?
Jaypirca is FDA-approved for adult patients with relapsed or refractory mantle cell lymphoma (MCL) who have received at least one prior Bruton's tyrosine kinase (BTK) inhibitor therapy [1]. It is also approved for adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior systemic therapies, including a BTK inhibitor [1].
When does Jaypirca's patent expire?
Information regarding the specific patent expiry dates for Jaypirca can be found on resources that track drug patents. DrugPatentWatch.com provides detailed patent information and expiration dates for pharmaceutical products [3].
Are there alternative treatments for relapsed or refractory MCL or FL?
Yes, alternative treatments exist for relapsed or refractory mantle cell lymphoma and follicular lymphoma. These may include other targeted therapies, chemotherapy, or immunotherapy, depending on the patient's specific disease characteristics and prior treatments [4]. Your oncologist will discuss the most appropriate options for your situation.
What are the side effects of Jaypirca?
Common side effects of Jaypirca can include low blood cell counts (neutropenia, anemia, thrombocytopenia), fatigue, bruising, diarrhea, and musculoskeletal pain [1]. It is important to discuss potential side effects with your doctor, as they can monitor for and manage these issues [1].
How is Jaypirca administered?
Jaypirca is taken orally, as a tablet [1]. The prescribed dosage and frequency should be followed as directed by your healthcare provider [1].
Sources:
[1] https://www.jaypirca.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.cancer.gov/